Bafna Pharmaceuticals Limited has intimated the stock exchanges about an upcoming board meeting pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board of Directors meeting is scheduled to be held on Tuesday, August 11, 2026. The primary agenda for the meeting is to consider and approve the Un-Audited Financial Results of the Company for the quarter ended June 30, 2026 (Q1 FY27).
In accordance with the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the company's shares remains closed for designated persons and their immediate relatives. The closure period is from July 01, 2026 to August 13, 2026 (both days inclusive). This trading restriction is specifically for the purpose of considering the Un-Audited Financial Results for the quarter ended June 30, 2026.
The company has requested the exchanges to take this information on record.
The disclosure is signed by Mohanachandran A, Company Secretary & Compliance Officer, with a digital signature timestamp of August 05, 2026 at 16:45:53 IST.